Delta Lloyd Asset Management N.V. purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 111,936 shares of the healthcare conglomerate’s stock, valued at approximately $20,755,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Swiss National Bank lifted its holdings in shares of UnitedHealth Group by 3.4% in the 2nd quarter. Swiss National Bank now owns 3,845,088 shares of the healthcare conglomerate’s stock worth $712,956,000 after purchasing an additional 125,600 shares during the last quarter. Bronfman E.L. Rothschild L.P. lifted its holdings in shares of UnitedHealth Group by 76.9% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 13,600 shares of the healthcare conglomerate’s stock worth $2,522,000 after purchasing an additional 5,912 shares during the last quarter. Mark Sheptoff Financial Planning LLC lifted its holdings in shares of UnitedHealth Group by 9.8% in the 2nd quarter. Mark Sheptoff Financial Planning LLC now owns 37,812 shares of the healthcare conglomerate’s stock worth $7,011,000 after purchasing an additional 3,367 shares during the last quarter. Commerce Bank lifted its holdings in shares of UnitedHealth Group by 120.7% in the 2nd quarter. Commerce Bank now owns 160,355 shares of the healthcare conglomerate’s stock worth $29,733,000 after purchasing an additional 87,704 shares during the last quarter. Finally, Wesbanco Bank Inc. lifted its holdings in shares of UnitedHealth Group by 1.2% in the 2nd quarter. Wesbanco Bank Inc. now owns 83,030 shares of the healthcare conglomerate’s stock worth $15,395,000 after purchasing an additional 946 shares during the last quarter. 86.14% of the stock is currently owned by institutional investors and hedge funds.

Several brokerages recently issued reports on UNH. Sanford C. Bernstein reissued an “outperform” rating and issued a $210.00 price target (up previously from $190.00) on shares of UnitedHealth Group in a report on Saturday, July 22nd. Royal Bank Of Canada reaffirmed a “buy” rating and set a $212.00 target price on shares of UnitedHealth Group in a research note on Thursday, July 20th. Citigroup Inc. lifted their target price on UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. Credit Suisse Group reaffirmed an “outperform” rating and set a $200.00 target price (up previously from $195.00) on shares of UnitedHealth Group in a research note on Thursday, July 13th. Finally, Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $205.00 target price (up previously from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Three research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $216.65.

In other news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the transaction, the director now owns 1,818,898 shares in the company, valued at $348,700,935.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders sold a total of 72,149 shares of company stock worth $14,212,342 over the last 90 days. Insiders own 0.89% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.watchlistnews.com/delta-lloyd-asset-management-n-v-takes-position-in-unitedhealth-group-incorporated-unh/1681972.html.

UnitedHealth Group Incorporated (NYSE UNH) opened at $212.87 on Monday. The company has a quick ratio of 0.72, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $205,815.48, a price-to-earnings ratio of 22.17, a P/E/G ratio of 1.58 and a beta of 0.64. UnitedHealth Group Incorporated has a 1-year low of $136.22 and a 1-year high of $213.83.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm posted $2.17 EPS. analysts anticipate that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.